Masimo | MASI - Capital Ordinário





Capital Ordinário Alterar Data
Abbott USD 1.74B 23.39B 2025-09
Accuray USD 100K 1000 2024-09
Align Technology USD 71.75M 736K 2025-12
AngioDynamics USD 41.57M 127K 2025-09
Artivion USD 47.84M 468K 2025-12
AtriCure USD 49.7M 10K 2025-09
Avanos Medical USD 46.46M 39.46K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 1.46B 2025-06
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 7.2M 2025-09
General Electric Aerospace USD 1.05B 6.05M 2025-12
Globus Medical USD 135.06M 449K 2025-12
Haemonetics USD 46.83M 82K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
Intuitive Surgical USD 354.5M 3.98M 2025-12
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Orthofix International USD 39.83M 315K 2025-12
Owens Minor USD 76.39M 911K 2025-12
ResMed USD 145.97M 25K 2025-12
Steris USD 98.15M 344K 2025-12
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12